Skip to main content

Table 3 Multiple Sclerosis Treatment Concern Questionnaire score for subscales relating to injection-site reactions and flu-like symptoms (mITT population)

From: Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV study

 

Injection-site reaction score

Flu-like symptom score

Observed

Paired change

Observed

Paired change

Week 4

 N (missing)

152 (5)

152 (2)

 Mean (SD)

11.2 (3.6)

11.1 (4.6)

 Median (range)

12 (1–20)

12 (1–20)

Week 12

 N (missing)

149 (2)

144 (7)

148 (3)

143 (8)

 Mean (SD)

12.3 (3.0)

1.1 (2.8)

10.8 (4.2)

–0.2 (4.3)

 Median (range)

13 (4–20)

1 (−6 to +12)

11 (1–20)

0 (–12 to +17)

Week 24

 N (missing)

137 (1)

133 (5)

137 (1)

133 (5)

 Mean (SD)

12.4 (3.0)

1.3 (3.1)

10.1 (4.3)

–0.8 (4.1)

 Median (range)

13 (1–18)

1 (−8 to +14)

10 (1–20)

–1 (–3 to +1)